Retraction
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Paper Information
Record ID:
44538
Author(s):
Journal:
Publication Date:
December 10, 2019
Retraction Date:
May 04, 2023
(2.6 years years ago)
Subjects:
Institutions:
- Nanotechnology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Medical Biotechnology, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Zeromskiego 113, Lodz, Poland
- Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
- Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
- School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Article Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (64)
64
Total Citations11
Post-Retraction(17.2%)
53
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
8
Within 1 year
0
After 2+ years
595
Days since retraction (latest)
The emerging landscape of peptide-based inhibitors of PCSK9
Benjamin J. Tombling, Yuhui Zhang, Yen‐Hua Huang et al. (5 authors)
Atherosclerosis
Published: Jun 2021
32 citations
32 citations
677 days before retraction
PCSK9 vaccine: so near, yet so far!
Amirhossein Sahebkar, Amir Abbas Momtazi‐Borojeni, Maciej Banach
European Heart Journal
Open Access
Published: Jun 2021
34 citations
34 citations
682 days before retraction
PCSK9 and cancer: Rethinking the link
Khadijeh Mahboobnia, Matteo Pirro, Ettore Marini et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: May 2021
81 citations
81 citations
706 days before retraction
PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
Amir Abbas Momtazi‐Borojeni, Mahmoud Reza Jaafari, Mohammad Afshar et al. (5 authors)
Archives of Medical Science
Open Access
Published: Mar 2021
49 citations
49 citations
777 days before retraction
Current Evidence and Future Directions of PCSK9 Inhibition
Jiaqian Xu, Michael D. Shapiro
US Cardiology Review
Open Access
Published: Feb 2021
2 citations
2 citations
807 days before retraction
Biological drug and drug delivery-mediated immunotherapy
Qingqing Xiao, Xiaotong Li, Yi Li et al. (7 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: Dec 2020
163 citations
163 citations
854 days before retraction
Peptidic vaccines: The new cure for heart diseases?
Carlos Enrique Guerrero-Beltrán, Ivan A Mijares-Rojas, Gustavo Salgado‐Garza et al. (5 authors)
Pharmacological Research
Published: Dec 2020
7 citations
7 citations
874 days before retraction
PCSK9Qβ-003 Vaccine Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice
Danyu Wu, Yajie Pan, Shijun Yang et al. (10 authors)
Cardiovascular Drugs and Therapy
Published: Jul 2020
26 citations
26 citations
1010 days before retraction
The role of interferon-γ in cardiovascular disease: an update
Ailin Elyasi, Iryna Voloshyna, Saba Ahmed et al. (7 authors)
Inflammation Research
Published: Jul 2020
66 citations
66 citations
1016 days before retraction
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats
Busarin Arunsak, Wasana Pratchayasakul, Patchareeya Amput et al. (11 authors)
Archives of Biochemistry and Biophysics
Published: Jun 2020
15 citations
15 citations
1044 days before retraction
New Pharmacological Approaches to Target PCSK9
Alberico L. Catapano, Angela Pirillo, Giuseppe Danilo Norata
Current Atherosclerosis Reports
Published: Jun 2020
57 citations
57 citations
1065 days before retraction
Surmounting the endothelial barrier for delivery of drugs and imaging tracers
Johan G. Schnitzler, Kim E. Dzobo, Nick S. Nurmohamed et al. (5 authors)
Atherosclerosis
Open Access
Published: May 2020
5 citations
5 citations
1088 days before retraction
Paper citing Therapeutic effect of nanoliposomal PCSK9 vaccine ...
Unknown Authors
Unknown Journal
Published: May 2020
1098 days before retraction
Targeting LDL cholesterol: Early treatment is key to population health
Jane K. Stock
Atherosclerosis
Published: Mar 2020
6 citations
6 citations
1129 days before retraction
Quick Stats
Total Citations:
64
Years Since Retraction:
2.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025